PRO1107 in Patients With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Endometrial Cancer|Ovarian Cancer|Triple Negative Breast Cancer|GastroEsophageal Cancer|Non-small Cell Lung Cancer|Urothelial Carcinoma
Interventions: DRUG: PRO1107
Sponsor: ProfoundBio US Co.